- Incyte (INCY, Financial) will announce its Q1 2025 financial results on April 29, 2025, at 7:00 a.m. ET.
- The company will hold a conference call and webcast at 8:00 a.m. ET on the same day.
- The conference call replay will be available for 30 days, and the webcast replay for 90 days.
Incyte Corporation (INCY), a prominent name in the biopharmaceutical sector, has announced the schedule for its first quarter 2025 financial results. The company will release its Q1 2025 financial results via a press release on April 29, 2025, at 7:00 a.m. Eastern Time (ET).
Following the release, Incyte will host a conference call and webcast at 8:00 a.m. ET. Investors interested in participating can access the call domestically by dialing 877-407-3042 or internationally at 201-389-0864, using the conference ID 13753168. For those unable to join at the scheduled time, a replay will be accessible for 30 days through dial-in numbers 877-660-6853 in the U.S., and 201-612-7415 internationally, with the same conference ID. Meanwhile, the webcast, complete with slides, will be available at Investor.Incyte.com and can be replayed for up to 90 days.
Incyte, headquartered in Wilmington, Delaware, is recognized for its dedication to solving unmet medical needs through innovative therapeutic solutions. Interested parties can learn more about the company and its portfolio of pioneering medicines by visiting Incyte.com.
